Cardium Therapeutics, Inc. 4
4 · Cardium Therapeutics, Inc. · Filed Mar 4, 2014
Insider Transaction Report
Form 4
Otremba Lon E
Director
Transactions
- Other
Warrant to purchase Common Stock
2014-02-28+50,000→ 60,000 totalExercise: $0.80From: 2014-02-28Exp: 2024-02-28→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]"Out-of-the-money" warrants were issued with an exercise price set at a 57% premium to the closing price of the Issuer's common stock on the issue date, and were acquired pursuant to a compensation and incentive arrangement in connection with which the reporting person's compensation as a director had been deferred.